153 related articles for article (PubMed ID: 30047091)
1. Inositol-C2-PAF acts as a biological response modifier and antagonizes cancer-relevant processes in mammary carcinoma cells.
Pelz C; Häckel S; Semini G; Schrötter S; Bintig W; Stricker S; Mrawietz G; Klein A; Lucka L; Shmanai V; Eickholt B; Hildmann A; Danker K
Cell Oncol (Dordr); 2018 Oct; 41(5):505-516. PubMed ID: 30047091
[TBL] [Abstract][Full Text] [Related]
2. The novel synthetic ether lipid inositol-C2-PAF inhibits phosphorylation of the tyrosine kinases Src and FAK independent of integrin activation in transformed skin cells.
Semini G; Hildmann A; Reissig HU; Reutter W; Danker K
Biochem Pharmacol; 2011 Apr; 81(8):985-95. PubMed ID: 21320472
[TBL] [Abstract][Full Text] [Related]
3. Glycosidated phospholipids - a promising group of anti-tumour lipids.
Semini G; Hildmann A; von Haefen C; Danker K
Anticancer Agents Med Chem; 2014 May; 14(4):607-17. PubMed ID: 24628240
[TBL] [Abstract][Full Text] [Related]
4. Glycosidated phospholipids: uncoupling of signalling pathways at the plasma membrane.
Danker K; Reutter W; Semini G
Br J Pharmacol; 2010 May; 160(1):36-47. PubMed ID: 20331609
[TBL] [Abstract][Full Text] [Related]
5. Impact of alkylphospholipids on the gene expression profile of HaCaT cells.
Semini G; Klein A; Danker K
Pharmacogenet Genomics; 2011 Jul; 21(7):375-87. PubMed ID: 21681147
[TBL] [Abstract][Full Text] [Related]
6. The ether lipid inositol-C2-PAF is a potent inhibitor of cell proliferation in HaCaT cells.
Fischer A; Müller D; Zimmermann-Kordmann M; Kleuser B; Mickeleit M; Laabs S; Löwe W; Cantagrel F; Reutter W; Danker K
Chembiochem; 2006 Mar; 7(3):441-9. PubMed ID: 16453359
[TBL] [Abstract][Full Text] [Related]
7. Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration.
Ravid D; Chuderland D; Landsman L; Lavie Y; Reich R; Liscovitch M
Exp Cell Res; 2008 Sep; 314(15):2762-73. PubMed ID: 18598695
[TBL] [Abstract][Full Text] [Related]
8. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
9. Inositol-C2-PAF down-regulates components of the antigen presentation machinery in a 2D-model of epidermal inflammation.
Semini G; Hildmann A; Klein A; Lucka L; Schön M; Schön MP; Shmanai V; Danker K
Biochem Pharmacol; 2014 Feb; 87(3):477-88. PubMed ID: 24291779
[TBL] [Abstract][Full Text] [Related]
10. Activation of c-Src/HER1/STAT5b and HER1/ERK1/2 signaling pathways and cell migration by hexachlorobenzene in MDA-MB-231 human breast cancer cell line.
Pontillo CA; García MA; Peña D; Cocca C; Chiappini F; Alvarez L; Kleiman de Pisarev D; Randi AS
Toxicol Sci; 2011 Apr; 120(2):284-96. PubMed ID: 21205633
[TBL] [Abstract][Full Text] [Related]
11. The COOH-terminus of the IGF-1Ec Isoform Enhances the Proliferation and Migration of Human MCF-7 Breast Cancer Cells.
Christopoulos PF; Papageorgiou E; Petraki C; Koutsilieris M
Anticancer Res; 2017 Jun; 37(6):2899-2912. PubMed ID: 28551627
[TBL] [Abstract][Full Text] [Related]
12. Inositoylated platelet-activating factor (Ino-C2-PAF) modulates dynamic lymphocyte-endothelial cell interactions and alleviates psoriasis-like skin inflammation in two complementary mouse models.
Forkel S; Schön M; Hildmann A; Claßen A; John SM; Danker K; Schön MP
J Invest Dermatol; 2014 Oct; 134(10):2510-2520. PubMed ID: 24714204
[TBL] [Abstract][Full Text] [Related]
13. Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.
Ibrahim YH; Byron SA; Cui X; Lee AV; Yee D
Mol Cancer Res; 2008 Sep; 6(9):1491-8. PubMed ID: 18819936
[TBL] [Abstract][Full Text] [Related]
14.
Lee SO; Lee MH; Lee KR; Lee EO; Lee HJ
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30845749
[No Abstract] [Full Text] [Related]
15. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.
Matà R; Palladino C; Nicolosi ML; Lo Presti AR; Malaguarnera R; Ragusa M; Sciortino D; Morrione A; Maggiolini M; Vella V; Belfiore A
Oncotarget; 2016 Feb; 7(7):7683-700. PubMed ID: 26655502
[TBL] [Abstract][Full Text] [Related]
16. PKCη is a negative regulator of AKT inhibiting the IGF-I induced proliferation.
Shahaf G; Rotem-Dai N; Koifman G; Raveh-Amit H; Frost SA; Livneh E
Exp Cell Res; 2012 Apr; 318(7):789-99. PubMed ID: 22305966
[TBL] [Abstract][Full Text] [Related]
17. Relative effects of phenolic constituents from Yucca schidigera Roezl. bark on Kaposi's sarcoma cell proliferation, migration, and PAF synthesis.
Balestrieri C; Felice F; Piacente S; Pizza C; Montoro P; Oleszek W; Visciano V; Balestrieri ML
Biochem Pharmacol; 2006 May; 71(10):1479-87. PubMed ID: 16580641
[TBL] [Abstract][Full Text] [Related]
18. Platelet-activating factor promotes motility in breast cancer cells and disrupts non-transformed breast acinar structures.
Anandi VL; Ashiq KA; Nitheesh K; Lahiri M
Oncol Rep; 2016 Jan; 35(1):179-88. PubMed ID: 26531049
[TBL] [Abstract][Full Text] [Related]
19. Lunasin suppresses the migration and invasion of breast cancer cells by inhibiting matrix metalloproteinase-2/-9 via the FAK/Akt/ERK and NF-κB signaling pathways.
Jiang Q; Pan Y; Cheng Y; Li H; Liu D; Li H
Oncol Rep; 2016 Jul; 36(1):253-62. PubMed ID: 27175819
[TBL] [Abstract][Full Text] [Related]
20. Cryptotanshinone inhibits cellular proliferation of human lung cancer cells through downregulation ofIGF-1R/PI3K/Akt signaling pathway.
Zhang J; Wen G; Sun L; Yuan W; Wang R; Zeng Q; Zhang G; Yu B
Oncol Rep; 2018 Nov; 40(5):2926-2934. PubMed ID: 30106122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
